Screener
ADMA Biologics ADMA Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Business Acquisitions Pro Forma Revenue by Business | ||||||
| ADMA Bio Manufacturing | $123.64M+1.4% | $113.74M0.0% | —— | —— | $121.95M— | |
| Plasma Collection Centers | $723K— | $716K-31.8% | —— | —— | $0— | |
| Revenue by Product | ||||||
| ASCENIV | $102.92M+23.5% | $97.49M+27.7% | —— | —— | $83.32M+39.1% | |
| BIVIGAM | $19.42M-48.5% | $15.42M-54.0% | —— | —— | $37.71M+6.0% | |
| Intermediates And Other | $1.3M+41.4% | $833K-78.5% | —— | —— | $917K-89.2% | |
| Revenue by Geography | ||||||
| Non Us | $1.08M— | $1.07M-73.8% | $1.79M-37.6% | $246K-95.2% | $0-100% | |
| US | $123.32M+1.1% | $113.43M+2.4% | $137.38M+19.8% | $133.98M+16.8% | $121.98M+18.7% |
FAQ
- How does ADMA Biologics break its business down?
- ADMA Biologics (ADMA) reports business acquisitions pro forma revenue by business across 2 parts — ADMA Bio Manufacturing and Plasma Collection Centers. Each is extracted from the segment footnotes and tracked over time.
- Where does ADMA Biologics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ADMA Biologics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
